Pliant Therapeutics, Inc. (PLRX) earnings
PLRX earnings moved a median of -1.58% by the close. Quarterly and annual PLRX reports and results, each read against the price at its own news timestamp. Back to the PLRX overview →
24 measured PLRX earnings events.
Where these PLRX earnings landedvs 24 measured PLRX earnings reactions
| Middle 50% of PLRX earnings reactions | -3.63% to +3.65% |
|---|---|
| Median reaction (to close) | -1.58% |
| Measured reactions | 24 |
Point-in-time · zero look-ahead
Half of the 24 PLRX earnings events with a measured close landed between -3.63% and +3.65%; 33% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q PLIANT THERAPEUTICS, For: Jun 30 | SEC filing · Form 10-Q | -1.35% | +2.88% | |
| Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results | Press release | -1.35% | +2.88% | |
| Form 10-Q PLIANT THERAPEUTICS, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -1.67% | |
| Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results | Press release | +0.00% | -1.67% | |
| Form 10-K PLIANT THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | +0.38% | +6.01% | |
| Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2025 Financial Results | Press release | +0.38% | +6.01% | |
| Form 10-Q PLIANT THERAPEUTICS, For: Sep 30 | SEC filing · Form 10-Q | +3.31% | +5.96% | |
| Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results | Press release | +3.31% | +5.96% | |
| Form 10-Q PLIANT THERAPEUTICS, For: Jun 30 | SEC filing · Form 10-Q | +3.85% | +6.41% | |
| Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results | Press release | +3.85% | +6.41% | |
| Form 10-Q PLIANT THERAPEUTICS, For: Mar 31 | SEC filing · Form 10-Q | +0.34% | -2.76% | |
| Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results | Press release | +0.34% | -2.76% | |
| Form 10-K PLIANT THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | -2.35% | -6.25% | |
| Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2024 Financial Results | Press release | -2.35% | -6.25% | |
| Form 10-Q PLIANT THERAPEUTICS, For: Sep 30 | SEC filing · Form 10-Q | -0.89% | -1.38% | |
| Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results | Press release | -0.89% | -1.38% | |
| Form 10-Q PLIANT THERAPEUTICS, For: Jun 30 | SEC filing · Form 10-Q | -2.54% | -2.70% | |
| Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results | Press release | -2.54% | -2.70% | |
| Form 10-Q PLIANT THERAPEUTICS, For: Mar 31 | SEC filing · Form 10-Q | -3.43% | -1.50% | |
| Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results | Press release | -3.43% | -1.50% | |
| Form 10-K PLIANT THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | -3.28% | -7.67% | |
| Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2023 Financial Results | Press release | -3.28% | -7.67% | |
| Form 10-Q PLIANT THERAPEUTICS, For: Sep 30 | SEC filing · Form 10-Q | +2.05% | -11.46% | |
| Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results | Press release | +2.05% | -11.46% |
Keep exploring
More PLRX: analyst actions → · SEC filings → · PLRX overview →